IndraLab

Statements



reach
"Very recently, it was demonstrated that spironolactone and its main metabolite, canrenoic acid (CA), inhibited Kv11.1 [human ether-a-go-go (HERG)] channel currents recorded in stably transfected Chine[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Both spironolactone (SP) and its main metabolite, canrenoic acid (CA), prolong cardiac action potential duration and decrease the Kv11.1 (HERG) current."